1-11 of 11
Ruediger Liersch
Close
Sort by
Journal Articles

Polatuzumab Vedotin in Relapsed and Refractory (r/r) Large B-Cell Lymphoma (LBCL): Real-World Data of the German National Compassionate Use Program (CUP)

Nora Liebers, MD, Johannes Duell, MD, Daniel Nörenberg, MD, Eva Kaebisch, MD, Andrea Kerkhoff, MD, Fabian Acker, MD, Stephan Fuhrmann, MD, Corinna Leng, MD PhD, Manfred Welslau, MD, Jens Chemnitz, MD, Jan Moritz Middeke, MD, Thomas Weber, MD, Ralf Ulrich Trappe, MD, Roald Pfannes, MD, Ruediger Liersch, MD, Christian Spoer, MD, Niklas Gebauer, MD, Stefan Fuxius, MD, Léandra Caillé, Christiane Pott, MD PhD, Christian Koenecke, MD, Udo Holtick, Thomas Geer, MD, Ulrich Keller, MD, Rainer Claus, MD, Dimitrios Mougiakakos, MD, Stephanie Mayer, MD, Andreas Hüttmann, MD, Arne Trummer, MD, Gerald Wulf, MD, Uta Brunnberg, MD, Lars Bullinger, MD, Georg Hess, MD, Carsten Mueller-Tidow, MD, Bertram Glass, MD, Georg Lenz, Peter Dreger, MD, Sascha Dietrich, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–13.
https://doi.org/10.1182/blood-2020-136539
Published: 2020
Journal Articles

A Prospective, Open-Label, Multicenter, Phase 2 Trial to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib (ONO/GS-4059) and Entospletinib with and without Obinutuzumab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Nadine Kutsch, MD, Christian Pallasch, Eugen Tausch, Volkmar Boehme, Matthias Ritgen, Ruediger Liersch, Alexander Wacker, Georg Jacobs, Ralf Ulrich Trappe, Peter Dreger, Stephan Stilgenbauer, Danjie Zhang, Juliane M. Jürgensmeier, Pankaj Bhargava, Michael Hallek, Barbara F. Eichhorst, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4297.
https://doi.org/10.1182/blood-2019-130912
Published: 2019
Journal Articles

Chemotherapy-Free Combination of Obinutuzumab and Ibrutinib in First LINE Treatment of Follicular Lymphoma. the Alternative Study By the German Low Grade Lymphoma Study Group (GLSG)

Christian Schmidt, MD, Anna-Katharina Zoellner, Vindi Jurinovic, Martin Sökler, MD, Roswitha Forstpointner, Sascha Haubner, MD, Christian Buske, MD, Andreas Viardot, MD, Ulrich Keller, Christiane Pott, Ullrich Graeven, MD, Reinhard Marks, Mathias Hänel, MD, Ruediger Liersch, Jan Dürig, Eva Hoster, Michael Unterhalt, Wolfgang Hiddemann
Journal: Blood
Blood (2018) 132 (Supplement 1): 448.
https://doi.org/10.1182/blood-2018-99-111692
Published: 2018
Journal Articles

Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients

Ruediger Liersch, Joachim Gerss, Christoph Schliemann, Michael Bayer, Christian Schwöppe, Christoph Biermann, Iris Appelmann, Torsten Kessler, Bob Löwenberg, Thomas Büchner, Wolfgang Hiddemann, Carsten Müller-Tidow, Wolfgang E. Berdel, Rolf Mesters
Journal: Blood
Blood (2012) 119 (22): 5215–5220.
https://doi.org/10.1182/blood-2011-11-389692
Published: 2012
Includes: Supplemental data
Journal Articles

Expression of Osteopontin in the Bone Marrow of Patients with Acute Myeloid Leukemia.

Ruediger Liersch, MD, Michael Bayer, Christoph Biermann, Iris Appelmann, Christoph Schliemann, MD, Christian Schwoeppe, Torsten Kessler, MD, Carsten Mueller-Tidow, MD, Wolfgang Berdel, Rolf Mesters
Journal: Blood
Blood (2009) 114 (22): 4694.
https://doi.org/10.1182/blood.V114.22.4694.4694
Published: 2009
Journal Articles

Targeting Tissue Factor to Tumor Vessels. Experimental Results and First-in-Man Experience.

Wolfgang E Berdel, MD, Torsten Kessler, MD, Christian Schwöppe, PhD, Ruediger Liersch, MD, Torsten Persigehl, MD, Christoph Bremer, MD, Christoph Schliemann, MD, Rolf Mesters, MD
Journal: Blood
Blood (2009) 114 (22): 469.
https://doi.org/10.1182/blood.V114.22.469.469
Published: 2009
Journal Articles

Pattern of Relapse in Localized Gastric Lymphoma Registered within the Prospective German Multicenter Study GIT NHL 01/92.

Ruediger Liersch, Wolfgang E. Berdel, Normann A. Willich, Gabriele Reinartz, Markus Tiemann, Peter Koch
Journal: Blood
Blood (2007) 110 (11): 1355.
https://doi.org/10.1182/blood.V110.11.1355.1355
Published: 2007
Journal Articles

Response Adapted Assignment of the Number of Chemotherapy Cycles for the Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Is Not Justified: Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Joerg Schubert, Marita Ziepert, Eva Lengfelder, PD, Martin Mohren, PD, Norma Peter, MD, Marcel Reiser, PD, Michael Clemens, Christina Nickenig, MD, Maike deWit, PD, Anthony Ho, Hartmut Eimermacher, MD, Lorenz Truemper, Martin Hoffmann, MD, Roland Mertelsmann, Bernd Metzner, MD, Hans-Guenther Mergenthaler, Ruediger Liersch, MD, Ulrich Duehrsen, Leopold Balleisen, Frank Hartmann, Viola Poeschel, Norbert Schmitz, Markus Loeffler, Michael Pfreundschuh
Journal: Blood
Blood (2007) 110 (11): 788.
https://doi.org/10.1182/blood.V110.11.788.788
Published: 2007
Journal Articles

Six vs. Eight Cycles of Bi-Weekly CHOP-14 with or without Rituximab for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the Completed RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Samira Zeynalova, Eva Lengfelder, M.D., Astrid Franke, M.D., Marcel Reiser, M.D., Hjalmar Steinhauer, M.D., Michael Clemens, M.D., Christina Nickenig, M.D., Maike de Wit, M.D., Bernd Metzner, M.D., Manfred Hensel, M.D., Hans-Guenther Mergenthaler, M.D., Ruediger Liersch, M.D., Ulrich Duehrsen, M.D., Leopold Balleisen, M.D., Monika Engelhardt, M.D., Viola Poeschel, M.D., Joerg Schubert, M.D., Lorenz Truemper, M.D., Norbert Schmitz, M.D., Markus Loeffler, M.D.
Journal: Blood
Blood (2006) 108 (11): 205.
https://doi.org/10.1182/blood.V108.11.205.205
Published: 2006
Journal Articles

Induction of lymphatic endothelial cell differentiation in embryoid bodies

Brief Report
Ruediger Liersch, Filip Nay, Lingge Lu, Michael Detmar
Journal: Blood
Blood (2006) 107 (3): 1214–1216.
https://doi.org/10.1182/blood-2005-08-3400
Published: 2006
Journal Articles

Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Rudolf Schmits, MD, Samira Zeynalova, Eva Lengfelder, MD, Astrid Franke, MD, Hans Steinhauer, MD, Marcel Reiser, MD, Michael Clemens, MD, Christine Nickenig, MD, Martha de Wit, MD, Martin Hoffmann, MD, Roland Mertelsmann, MD, Bernd Metzner, MD, Anthony Ho, MD, Lorenz Truemper, MD, Hans Eimermacher, MD, Hans Mergenthaler, MD, Ruediger Liersch, MD, Ulrich Duehrsen, MD, Leopold Balleisen, MD, Frank Hartmann, MD, Viola Poeschel, MD, Norbert Schmitz, MD, Markus Loeffler, MD
Journal: Blood
Blood (2005) 106 (11): 13.
https://doi.org/10.1182/blood.V106.11.13.13
Published: 2005